FI896095A0 - Foerfarande foer eterifiering och dealkylering av piperidinderivat och mellanprodukter. - Google Patents

Foerfarande foer eterifiering och dealkylering av piperidinderivat och mellanprodukter.

Info

Publication number
FI896095A0
FI896095A0 FI896095A FI896095A FI896095A0 FI 896095 A0 FI896095 A0 FI 896095A0 FI 896095 A FI896095 A FI 896095A FI 896095 A FI896095 A FI 896095A FI 896095 A0 FI896095 A0 FI 896095A0
Authority
FI
Finland
Prior art keywords
och
piperidinderivat
eterifiering
dealkylering
mellanprodukter
Prior art date
Application number
FI896095A
Other languages
English (en)
Inventor
Jane Marie Lundbeck
Peer Everland
Svend Treppendahl
Palle Jakobsen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of FI896095A0 publication Critical patent/FI896095A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI896095A 1988-12-22 1989-12-19 Foerfarande foer eterifiering och dealkylering av piperidinderivat och mellanprodukter. FI896095A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK715988A DK715988D0 (da) 1988-12-22 1988-12-22 Etherifikation og dealkylering af piperidin-derivater samt intermediater

Publications (1)

Publication Number Publication Date
FI896095A0 true FI896095A0 (fi) 1989-12-19

Family

ID=8149231

Family Applications (1)

Application Number Title Priority Date Filing Date
FI896095A FI896095A0 (fi) 1988-12-22 1989-12-19 Foerfarande foer eterifiering och dealkylering av piperidinderivat och mellanprodukter.

Country Status (10)

Country Link
EP (1) EP0374674A2 (fi)
JP (1) JPH02225464A (fi)
AU (1) AU4692789A (fi)
CA (1) CA2005354A1 (fi)
DK (1) DK715988D0 (fi)
FI (1) FI896095A0 (fi)
IL (1) IL92681A0 (fi)
NO (1) NO895194L (fi)
PT (1) PT92715A (fi)
ZA (1) ZA899779B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
EP0755923B1 (en) * 1995-01-23 2005-05-04 Daiichi Suntory Pharma Co., Ltd. Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
JPH11505229A (ja) * 1995-05-17 1999-05-18 ノボ ノルディスク アクティーゼルスカブ 4−アリール−ピペリジン誘導体を製造する方法
WO1997009311A1 (de) * 1995-09-07 1997-03-13 F. Hoffmann-La Roche Ag Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
GB9700690D0 (en) 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
WO1998045263A1 (en) * 1997-04-07 1998-10-15 Georgetown University Analogs of cocaine
EA199901098A1 (ru) 1997-05-29 2000-08-28 Смитклайн Бичам Корпорейшн Новый способ
AU3108097A (en) 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB9923540D0 (en) * 1999-10-05 1999-12-08 Smithkline Beecham Plc Novel process
CA2433605A1 (en) * 2001-01-04 2002-07-11 Ferrer Internacional, S.A. Process for preparing (.plusmn.) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine

Also Published As

Publication number Publication date
IL92681A0 (en) 1990-09-17
DK715988D0 (da) 1988-12-22
CA2005354A1 (en) 1990-06-22
EP0374674A2 (en) 1990-06-27
PT92715A (pt) 1990-06-29
NO895194L (no) 1990-06-25
AU4692789A (en) 1990-06-28
NO895194D0 (no) 1989-12-21
ZA899779B (en) 1990-09-26
JPH02225464A (ja) 1990-09-07

Similar Documents

Publication Publication Date Title
FI882190A0 (fi) Foerfarande och anordning foer analysering av en materialbana.
FI881619A0 (fi) Foerfarande och anordning foer dosering av tvaettmedel.
FI881725A (fi) Foerfarande och anordning foer behandling av fibersuspensioner.
FI881753A (fi) Foerfarande och anordning foer framstaellning av ackumulatorskivor.
FI881754A0 (fi) Anordning foer ansyrning och foerladdning av ackumulatorer.
FI881857A0 (fi) Foerfarande och anordning foer inspektion av spegelreflexionsytor.
FI882901A0 (fi) Foerfarande och anordning foer producering av en felfaergsbild.
FI880560A (fi) Foerfarande och anordning foer foerbehandling av cellulosahaltigt raoaemne.
FI881306A0 (fi) Foerfarande och anordning foer vaermebehandling av icke-komposterbara hushaollsavfall.
FI880245A0 (fi) Foerfarande och anordning foer aotervinning av kemikalier fraon natriumkarbonathaltig smaelta fraon foerbraenning av massaavlut.
FI882010A0 (fi) Foerfarande och anordning foer avlaegsnande av en fraktion fraon en kondensor.
FI881764A (fi) Skida foer foerbaettring av fristils- aokning och slalomaokning.
FI880314A0 (fi) Foerfarande och komponentsats foer sjaelvframstaellning av klaedesplagg.
FI881532A0 (fi) Foerfarande och anordning foer testning av ledningssatser.
FI881448A0 (fi) Foerfarande och anordning foer kylning av livsmedelsmaterial.
FI881430A (fi) Foerfarande och anordning foer aostadkommande av aosodling.
FI880956A0 (fi) Foerfarande och anordning foer saogning av virke.
FI880877A0 (fi) Anordningar och foerfarande foer skoetsel av graesplaner.
FI881905A (fi) Foerfarande foer foerbaettring av degens egenskaper och broedets kvalitet.
FI880572A0 (fi) Foerbindningsbalk och foerfarande foer framstaellning och montering av denna.
FI882112A0 (fi) Anordning foer taetning av en roergenomfoering och foerfarande foer tillverkning av anordningen.
FI882184A0 (fi) Foerfarande och anordning foer upptinande av en vaegtrumma.
FI880356A0 (fi) Rengoeringsfoerfarande foer transportband och anordning foer genomfoerande av foerfarandet.
FI881712A0 (fi) Foerfarande och anordning foer spridning av traespaon.
FI882274A (fi) Foerfarande foer maetning av belaeggning av pappret och anordning foer tillaempning av foerfarandet.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: NOVO NORDISK A/S